Partner Content Partner Content Mike Page, Alexion Pharmaceuticals invite to SMi's Orphan Dr... Mike Page, invite to Orphan Drugs & Rare Diseases
Events Partner Content SMi's 9th Annual Orphan Drugs & Rare Diseases Conference Orphan Drugs & Rare Diseases
Partner Content Partner Content Registration Opens for SMi’s 9th Annual Orphan Drugs & Rare ... Registration Opens for Orphan Drugs
Views & Analysis Patient access at risk: should stakeholders take an orchestr... Now is the time to work more harmoniously together to improve patient access to innovative treatments.
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
